The data is based on an ongoing government survey involving 6,538 patients, as of September. The information was disclosed in a reply to a parliamentary inquiry, using the Federal Institute for Drugs and Medical Devices (BfArM) as the data source.

 

All details here

New data reveals top medical conditions for which cannabis is reimbursed in Germany